This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Thursday, April 25, 2013
EASL: Watch HEPATITIS C - NEW DAA's READY FOR PRIME TIME
No comments:
Post a Comment